These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38526694)

  • 1. Is ALPPS still appropriate for large or locally advanced hepatocellular carcinoma in an era of targeted agents and immunotherapy?
    Lu YX; Zhao JP; Zhang WG
    Updates Surg; 2024 Jun; 76(3):899-910. PubMed ID: 38526694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALPPS Versus Portal Vein Embolization for Hepatitis-related Hepatocellular Carcinoma: A Changing Paradigm in Modulation of Future Liver Remnant Before Major Hepatectomy.
    Chan A; Zhang WY; Chok K; Dai J; Ji R; Kwan C; Man N; Poon R; Lo CM
    Ann Surg; 2021 May; 273(5):957-965. PubMed ID: 31305284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients.
    Charalel RA; Sung J; Askin G; Jo J; Mitry M; Chung C; Tmanova L; Madoff DC
    Curr Oncol Rep; 2021 Oct; 23(11):135. PubMed ID: 34716800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma with macrovascular invasion: a single-center retrospective analysis.
    Ye C; Ou M; Wen Z; Xu B; Lu T; Guo Y; Sun X
    World J Surg Oncol; 2024 Sep; 22(1):260. PubMed ID: 39342303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associating liver partition with portal vein ligation and staged hepatectomy (ALPPS) for the treatment of liver tumors in children.
    Wiederkehr JC; Avilla SG; Mattos E; Coelho IM; Ledesma JA; Conceição AF; Wiederkehr HA; Wiederkehr BA
    J Pediatr Surg; 2015 Jul; 50(7):1227-31. PubMed ID: 25783345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of split completeness on future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma: Complete-ALPPS versus partial-ALPPS.
    Chan ACY; Chok K; Dai JWC; Lo CM
    Surgery; 2017 Feb; 161(2):357-364. PubMed ID: 27596751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical modifications and outcomes after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) for primary liver malignancies: A systematic review.
    Baili E; Tsilimigras DI; Moris D; Sahara K; Pawlik TM
    Surg Oncol; 2020 Jun; 33():70-80. PubMed ID: 32561102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery.
    Zhang GQ; Zhang ZW; Lau WY; Chen XP
    Int J Surg; 2014; 12(5):437-41. PubMed ID: 24704086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Greater hypertrophy can be achieved with associating liver partition with portal vein ligation for staged hepatectomy compared to conventional staged hepatectomy, but with a higher price to pay?
    Chia DKA; Yeo Z; Loh SEK; Iyer SG; Bonney GK; Madhavan K; Kow AWC
    Am J Surg; 2018 Jan; 215(1):131-137. PubMed ID: 28859921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach.
    Shindoh J; Vauthey JN; Zimmitti G; Curley SA; Huang SY; Mahvash A; Gupta S; Wallace MJ; Aloia TA
    J Am Coll Surg; 2013 Jul; 217(1):126-33; discussion 133-4. PubMed ID: 23632095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-Stage Hepatectomy and ALPPS for Advanced Bilateral Liver Metastases: a Tailored Approach Balancing Risk and Outcome.
    Baumgart J; Jungmann F; Bartsch F; Kloth M; Mittler J; Heinrich S; Lang H
    J Gastrointest Surg; 2019 Dec; 23(12):2391-2400. PubMed ID: 30820795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous portal and hepatic vein embolization is better than portal embolization or ALPPS for hypertrophy of future liver remnant before major hepatectomy: A systematic review and network meta-analysis.
    Gavriilidis P; Marangoni G; Ahmad J; Azoulay D
    Hepatobiliary Pancreat Dis Int; 2023 Jun; 22(3):221-227. PubMed ID: 36100542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associating liver partition and portal vein ligation for staged hepatectomy versus sequential transarterial chemoembolization and portal vein embolization in staged hepatectomy for HBV-related hepatocellular carcinoma: a randomized comparative study.
    Li PP; Huang G; Jia NY; Pan ZY; Liu H; Yang Y; He CJ; Lau WY; Yang YF; Zhou WP
    Hepatobiliary Surg Nutr; 2022 Feb; 11(1):38-51. PubMed ID: 35284529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management.
    Truant S; Scatton O; Dokmak S; Regimbeau JM; Lucidi V; Laurent A; Gauzolino R; Castro Benitez C; Pequignot A; Donckier V; Lim C; Blanleuil ML; Brustia R; Le Treut YP; Soubrane O; Azoulay D; Farges O; Adam R; Pruvot FR;
    Eur J Surg Oncol; 2015 May; 41(5):674-82. PubMed ID: 25630689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative strategies to improve resectability for hepatocellular carcinoma: a systematic review and meta-analysis.
    Tustumi F; Ernani L; Coelho FF; Bernardo WM; Junior SS; Kruger JAP; Fonseca GM; Jeismann VB; Cecconello I; Herman P
    HPB (Oxford); 2018 Dec; 20(12):1109-1118. PubMed ID: 30057123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chance and challenge of associating liver partition and portal vein ligation for staged hepatectomy.
    Xiang F; Hu ZM
    Hepatobiliary Pancreat Dis Int; 2019 Jun; 18(3):214-222. PubMed ID: 31056484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors Versus Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma with First- or Lower-Order Portal Vein Tumor Thrombosis.
    Zhang JX; Cheng Y; Wei J; Fan WL; Liu J; Zhou CG; Liu S; Shi HB; Chu XY; Zheng WL; Zu QQ
    Cardiovasc Intervent Radiol; 2024 Jun; 47(6):751-761. PubMed ID: 38671322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Unresectable Hepatitis B Virus-related Hepatocellular Carcinoma: A Single Center Study of 45 Patients.
    Wang Z; Peng Y; Hu J; Wang X; Sun H; Sun J; Shi Y; Xiao Y; Ding Z; Yang X; Tang M; Tang Z; Wang J; Lau WY; Fan J; Zhou J
    Ann Surg; 2020 Mar; 271(3):534-541. PubMed ID: 29995681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization.
    Matsuo K; Murakami T; Kawaguchi D; Hiroshima Y; Koda K; Yamazaki K; Ishida Y; Tanaka K
    Surgery; 2016 May; 159(5):1289-98. PubMed ID: 26775576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis.
    Schadde E; Ardiles V; Slankamenac K; Tschuor C; Sergeant G; Amacker N; Baumgart J; Croome K; Hernandez-Alejandro R; Lang H; de Santibaňes E; Clavien PA
    World J Surg; 2014 Jun; 38(6):1510-9. PubMed ID: 24748319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.